XML 38 R26.htm IDEA: XBRL DOCUMENT
v3.20.2

Segment Information | 6 Months Ended
--- | ---
Jun. 27, 2020
Segment Reporting [Abstract] |
Segment Information | Note 20: Segment Information We operate within targeted markets through three reportable segments for continuing operations: biotechnology, recycling, and technology. The biotechnology segment started in September 2019 as the Company broadened its business perspectives to being a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The recycling segment includes all fees charged and costs incurred for collecting, recycling and installing appliances for utilities and other customers. The recycling segment also includes byproduct revenue, which is primarily generated through the recycling of appliances. The nature of products, services and customers for both segments varies significantly. Our technology segment is comprised of GeoTraq, which is in the process of developing technology to enable low cost, location-based products and services. As such, the segments are managed separately. Our Chief Executive Officer has been identified as the Chief Operating Decision Maker (“CODM”). The CODM evaluates performance and allocates resources based on sales and income from operations of each segment. Income (loss) from operations represents revenues less cost of revenues and operating expenses, including certain allocated selling, general and administrative costs. There are no intersegment sales or transfers. The following tables present our segment information for the 13 and 26 weeks ended June 27, 2020 and June 29, 2019:
|  | Thirteen Weeks Ended |  |  | Twenty Six Weeks Ended |
|  | June 27, 2020 |  |  | June 29, 2019 |  |  | June 27, 2020 |  |  | June 29, 2019 |
Revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recycling |  | $ | 4,007 |  |  | $ | 7,601 |  |  | $ | 12,457 |  |  | $ | 13,894 |
Biotechnology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Technology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Revenues |  | $ | 4,007 |  |  | $ | 7,601 |  |  | $ | 12,457 |  |  | $ | 13,894 |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recycling |  | $ | 1,045 |  |  | $ | 1,868 |  |  | $ | 2,519 |  |  | $ | 3,017 |
Biotechnology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Technology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Gross profit |  | $ | 1,045 |  |  | $ | 1,868 |  |  | $ | 2,519 |  |  | $ | 3,017 |
Operating loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recycling |  | $ | (846 | ) |  | $ | (1,218 | ) |  | $ | (2,775 | ) |  | $ | (2,881 | )
Biotechnology |  |  | (464 | ) |  |  | — |  |  |  | (807 | ) |  |  | — |
Technology |  |  | (1,008 | ) |  |  | (1,171 | ) |  |  | (2,135 | ) |  |  | (2,383 | )
Total Operating loss |  | $ | (2,318 | ) |  | $ | (2,389 | ) |  | $ | (5,717 | ) |  | $ | (5,264 | )
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recycling |  | $ | 91 |  |  | $ | — |  |  | $ | 171 |  |  | $ | 99 |
Biotechnology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Technology |  |  | 936 |  |  |  | 936 |  |  |  | 1,873 |  |  |  | 1,871 |
Total Depreciation and amortization |  | $ | 1,027 |  |  | $ | 936 |  |  | $ | 2,044 |  |  | $ | 1,970 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recycling |  | $ | 54 |  |  | $ | 14 |  |  | $ | 167 |  |  | $ | 6 |
Biotechnology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Technology |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Interest expense, net |  | $ | 54 |  |  | $ | 14 |  |  | $ | 167 |  |  | $ | 6 |
Net loss before benefit from income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Recycling |  | $ | (841 | ) |  | $ | (451 | ) |  | $ | (2,072 | ) |  | $ | (2,109 | )
Biotechnology |  |  | (464 | ) |  |  | — |  |  |  | (807 | ) |  |  | — |
Technology |  |  | (1,075 | ) |  |  | (1,313 | ) |  |  | (2,195 | ) |  |  | (2,383 | )
Total Net loss before benefit from income taxes |  | $ | (2,380 | ) |  | $ | (1,764 | ) |  | $ | (5,074 | ) |  | $ | (4,492 | )
|  | As of June 27, 2020 |  |  | As of December 28, 2019 |
Assets |  |  |  |  |  |  |  |
Recycling |  | $ | 10,392 |  |  | $ | 11,505 |
Biotechnology |  |  | — |  |  |  | — |
Technology |  |  | 15,629 |  |  |  | 17,529 |
Total Assets |  | $ | 26,021 |  |  | $ | 29,034 |
Intangible assets |  |  |  |  |  |  |  |
Recycling |  | $ | 19 |  |  | $ | 465 |
Biotechnology |  |  | — |  |  |  | — |
Technology |  |  | 15,797 |  |  |  | 17,240 |
Total Intangible assets |  | $ | 15,816 |  |  | $ | 17,705 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration